-
-
-
-
-
-
-
Ladenburg Thalmann Downgrades Kala Bio (KALA) to Neutral
-
-
-
-
-
-
-
KALA BIO completes enrollment in CHASE trial for eye disease treatment
-
-
-
-
-
-
-
KALA BIO (KALA) Announces Chief Executive Officer Transition
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

